Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep 30;13(19):4914.
doi: 10.3390/cancers13194914.

Etiologies of Melanoma Development and Prevention Measures: A Review of the Current Evidence

Affiliations
Review

Etiologies of Melanoma Development and Prevention Measures: A Review of the Current Evidence

Amir Reza Djavid et al. Cancers (Basel). .

Abstract

(1) Melanoma is the most aggressive dermatologic malignancy, with an estimated 106,110 new cases to be diagnosed in 2021. The annual incidence rates continue to climb, which underscores the critical importance of improving the methods to prevent this disease. The interventions to assist with melanoma prevention vary and typically include measures such as UV avoidance and the use of protective clothing, sunscreen, and other chemopreventive agents. However, the evidence is mixed surrounding the use of these and other interventions. This review discusses the heritable etiologies underlying melanoma development before delving into the data surrounding the preventive methods highlighted above. (2) A comprehensive literature review was performed to identify the clinical trials, observational studies, and meta-analyses pertinent to melanoma prevention and incidence. Online resources were queried to identify epidemiologic and clinical trial information. (3) Evidence exists to support population-wide screening programs, the proper use of sunscreen, and community-targeted measures in the prevention of melanoma. Clinical evidence for the majority of the proposed preventive chemotherapeutics is presently minimal but continues to evolve. (4) Further study of these chemotherapeutics, as well as improvement of techniques in artificial intelligence and imaging techniques for melanoma screening, is warranted for continued improvement of melanoma prevention.

Keywords: UV; artificial intelligence; melanoma; prevention; screening; sun safety; sunscreen; tanning.

PubMed Disclaimer

Conflict of interest statement

A.R.D., C.S., B.T.F., S.W.W., M.A.T., B.D.K. and J.M.G. have no disclosures to report. L.J.G. discloses research support/PI from Helsinn Group, J&J, Mallinckrodt, Kyowa Kirin, Soligenix, Innate, miRagen, Galderma, Merck, BMS, and Stratpharma; the speakers’ bureau for Helsinn Group and J&J; and the scientific advisory board for Helsinn Group, J&J, Mallinckrodt, Kyowa Kirin, Regeneron, and Sanofi. Y.M.S. discloses research funding from Amgen, Regeneron, Roche, Tempest Therapeutics, and IP in a small biomarker startup named Wasaba.

References

    1. Stern R.S. Prevalence of a history of skin cancer in 2007: Results of an incidence-based model. Arch. Dermatol. 2010;146:279–282. doi: 10.1001/archdermatol.2010.4. - DOI - PubMed
    1. Cancer Stat Facts: Melanoma of the Skin. 2021. [(accessed on 30 June 2021)]; Available online: https://seer.cancer.gov/statfacts/html/melan.html.
    1. Siegel R.L., Miller K.D., Fuchs H.E., Jemal A. Cancer Statistics, 2021. CA Cancer J. Clin. 2021;71:7–33. doi: 10.3322/caac.21654. - DOI - PubMed
    1. Guy G.P., Jr., Thomas C.C., Thompson T., Watson M., Massetti G.M., Richardson L.C., Centers for Disease Control and Prevention (CDC) Vital signs: Melanoma incidence and mortality trends and projections—United States, 1982-2030. MMWR Morb. Mortal. Wkly. Rep. 2015;64:591–596. - PMC - PubMed
    1. Jerant A.F., Johnson J.T., Sheridan C.D., Caffrey T.J. Early detection and treatment of skin cancer. Am. Fam. Physician. 2000;62:352–381. - PubMed

LinkOut - more resources